https://www.thebodypro.com/author/boehringer-ingelheim

Boehringer Ingelheim

Latest by Boehringer Ingelheim

Promo Image

Study of Tipranavir for First-Line Treatment Ends Early

Ingelheim/Germany -- Boehringer Ingelheim is actively conducting a clinical trial program to further evaluate Aptivus® (tipranavir) capsules for the treatment of HIV-1 infection. The program is comprised of ongoing and planned studies in more than 1,...

By Boehringer Ingelheim